Year 3Pharmacotherapeutics-II10 min readOfficial Syllabus

Tuberculosis

Curriculum Unit: 1. Infectious disease:

Overview & Academic Context

This study module covers "Tuberculosis", an integral component of the Year 3 Doctor of Pharmacy (Pharm.D) curriculum under Pharmacotherapeutics-II (Infectious disease). Designed for clinical pharmacy scholars, the syllabus emphasizes mechanistic understanding, clinical relevance, and high-yield examination competencies.

Core Study Concepts

TuberculosisInfectious disease

Learning Objectives

Upon reviewing this syllabus topic, Pharm.D students are expected to demonstrate proficiency in:

Understand the foundational etiology, classification, and clinical significance of Tuberculosis.
Analyze the underlying pathophysiology and disease manifestations relevant to Infectious disease.
Evaluate evidence-based pharmacotherapeutic management, therapeutic drug choices, and dosage individualization.
Identify critical patient monitoring parameters, adverse drug reactions (ADRs), and drug-drug interactions.

Full Study Notes & Interactive Hub

Unlock Complete Interactive Notes for Tuberculosis

Access clinical pathophysiology flowcharts, high-yield treatment algorithms, dose adjustment tables, AMBOSS-style search, interactive self-assessment quizzes, and board-exam mnemonics.

Protected educational content reserved for authorized Pharm.D students and faculty.

Curriculum References & Recommended Texts

Standard literature and institutional sources for Pharmacotherapeutics-II:

[1]Pharmacy Council of India (PCI) Pharm.D Curriculum Syllabus Guidelines
[2]Pharmacotherapy: A Pathophysiologic Approach (Joseph T. DiPiro et al.)
[3]Koda-Kimble and Young's Applied Therapeutics: The Clinical Use of Drugs
[4]Standard National and International Clinical Practice Guidelines (WHO, ACC/AHA, IDSA)